02.06.18
Frutarom Industries Ltd. has purchased 100% of the shares of I.B.R – Israeli Biotechnology Research Ltd. for approximately $21 million. Established in 1995, IBR researches, develops, manufactures and markets innovative and proprietary natural active ingredients for the cosmetics and dietary supplements industries, mainly for cellular and skin anti-aging, skin protection from UV rays and air pollution, skin whitening and pigmentation prevention.
IBR's sales turnover in 2017 was approximately $7.4M million, and in the past four years it has exhibited an average annual growth rate of 20%, and a 40% growth this past year, according to Frutarom.
IBR has R&D labs and a production facility in Yavne, Israel and it employs approximately 30 employees.
The acquisition is the continuation of the implementation of Frutarom’s strategy to establish its position as a leading global supplier of unique natural products, and will be joining Frutarom's growing activities in the fields of algae-growth and active ingredients extraction for personal care and skin protection, sold to some of the world's leading cosmetics companies.
IBR's sales turnover in 2017 was approximately $7.4M million, and in the past four years it has exhibited an average annual growth rate of 20%, and a 40% growth this past year, according to Frutarom.
IBR has R&D labs and a production facility in Yavne, Israel and it employs approximately 30 employees.
The acquisition is the continuation of the implementation of Frutarom’s strategy to establish its position as a leading global supplier of unique natural products, and will be joining Frutarom's growing activities in the fields of algae-growth and active ingredients extraction for personal care and skin protection, sold to some of the world's leading cosmetics companies.